Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmacogenomics
|
January 20, 2012
A predictive model for efavirenz dosing
Chad Brown, Alison A Motsinger-Reif
American Journal of Lifestyle Medicine
|
July 14, 2025
Alcohol Harms, Injuries, and Health: Clinical Implications for Lifestyle Medicine
David A Sleet, William Scarbrough, Chad Brown, et al.
Molecular Pharmaceutics
|
March 29, 2016
Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion
Paul Harmon, Kendra Galipeau, Wei Xu, et al.
International Journal of Pharmaceutics
|
March 26, 2016
Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug
Amitava Mitra, Li Li, Patrick Marsac, et al.
Frontiers in Genetics
|
February 4, 2012
A comparison of association methods for cytotoxicity mapping in pharmacogenomics
Chad Brown, Tammy M Havener, Lorraine Everitt, et al.
Proceedings. American Statistical Association. Annual Meeting
|
January 11, 2019
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics
Alison Motsinger-Reif, Chad Brown, Tammy Havener, et al.
Canadian Medical Education Journal
|
September 23, 2024
Sexual and gender minority health: a roadmap for developing evidence-based medical school curricula
Catherine Giffin, Sari Glow, Douglas Michael Lebo, et al.
Resuscitation
|
July 10, 2002
HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury
Laurence M Katz, James E Manning, Shane McCurdy, et al.
CJC Open
|
March 12, 2020
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods Study
Raymond Y Cho, Jian Weng, Kelsey Lynch, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
Diana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmacogenomics
|
January 20, 2012
A predictive model for efavirenz dosing
Chad Brown, Alison A Motsinger-Reif
American Journal of Lifestyle Medicine
|
July 14, 2025
Alcohol Harms, Injuries, and Health: Clinical Implications for Lifestyle Medicine
David A Sleet, William Scarbrough, Chad Brown, et al.
Molecular Pharmaceutics
|
March 29, 2016
Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion
Paul Harmon, Kendra Galipeau, Wei Xu, et al.
International Journal of Pharmaceutics
|
March 26, 2016
Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug
Amitava Mitra, Li Li, Patrick Marsac, et al.
Frontiers in Genetics
|
February 4, 2012
A comparison of association methods for cytotoxicity mapping in pharmacogenomics
Chad Brown, Tammy M Havener, Lorraine Everitt, et al.
Proceedings. American Statistical Association. Annual Meeting
|
January 11, 2019
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics
Alison Motsinger-Reif, Chad Brown, Tammy Havener, et al.
Canadian Medical Education Journal
|
September 23, 2024
Sexual and gender minority health: a roadmap for developing evidence-based medical school curricula
Catherine Giffin, Sari Glow, Douglas Michael Lebo, et al.
Resuscitation
|
July 10, 2002
HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury
Laurence M Katz, James E Manning, Shane McCurdy, et al.
CJC Open
|
March 12, 2020
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods Study
Raymond Y Cho, Jian Weng, Kelsey Lynch, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
Diana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
Page
of 2